FOLH1 and prostate carcinoma: Sommer et al. assessed PSMA expression using IHC in prostate carcinoma tissue before and during androgen deprivation therapy in 35 treatment-naïve patients, 55 tissue samples of patients under ADT, and 15 tissue samples from patients under ADT + NHT [41].